RecruitingNCT06762496

A New Tool to Promote Patient's Engagement in Their Healthcare Process

Development and Testing of a Patient's Decision Aid for Early Breast Cancer: a New Tool to Promote Patient's Engagement in Their Healthcare Process

Sponsor

European Institute of Oncology

Enrollment

180 participants

Start Date

Jan 22, 2025

Study Type

OBSERVATIONAL

Conditions

Breast Carcinoma Breast Cancer Stage I Breast Cancer Stage II

Summary

Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice. Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new digital tool designed to help women with early-stage, operable breast cancer become more engaged in their own care and treatment decisions — for example, through better communication with their healthcare team. **You may be eligible if...** - You are 18 or older - You have been diagnosed with early-stage, resectable (surgically removable) breast cancer - You are currently receiving or will be receiving treatment for early breast cancer - You do not have significant psychological or cognitive difficulties **You may NOT be eligible if...** - You have advanced, metastatic, or locally unresectable breast cancer - You have significant psychological illness, neurological disorders, or cognitive impairment - You have a history of substance abuse that would interfere with participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHealthcare professionals

healthcare professionals (HCPs) targeted, including team members: we will involve 30 physicians (who are involved in the process of care towards patients with early breast cancer (10 oncologists, 10 breast surgeon, and 10 breast radiologists specifically) for the semi-structured interviews

OTHERPatients PDA group

Participants will receive via mail the final version of the PDA and a Qualtrics link with a battery of questionnaires

OTHERPatients control group

Participants will receive only the online link with the battery of questionnaires

Locations(1)

European Institute of Oncology

Milan, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06762496

Related Trials

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT0699589837 locations

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

NCT050568571 location

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

NCT0561210023 locations

Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma

NCT045626231 location